Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status

Download All
Get up to date on best practices for assessing HER2 status and treating patients with HER2-low breast cancer with downloadable slides from a satellite symposium at SABCS 2022, an on-demand webcast, and an expert commentary.
person default
Nadia Harbeck, MD, PhD
Komal Jhaveri, MD
Heather McArthur, MD, MPH

Downloadable Slidesets

Review the latest evidence on HER2 testing, clinical implications of HER2-low status in advanced breast cancer, and mastering the safety profile of antibody-drug conjugates, including current guidelines and expert’s recommendations.

person default Nadia Harbeck, MD, PhD Komal Jhaveri, MD Heather McArthur, MD, MPH Released: December 8, 2022

Download this short summary slideset of key takeaways from a live satellite symposium on new developments in precision care for advanced HER2-low breast cancer.

person default Nadia Harbeck, MD, PhD Komal Jhaveri, MD Heather McArthur, MD, MPH Released: December 16, 2022

OnDemand

In this on-demand webcast from a live symposium, Nadia Harbeck, MD, PhD; Komal Jhaveri, MD; and Heather McArthur, MD, MPH, discuss current guidelines for the assessment of HER2 status in advanced breast cancer, including expanding the spectrum of HER2 positivity and mastering the use and safety of novel antibody–drug conjugates.

person default Nadia Harbeck, MD, PhD Komal Jhaveri, MD Heather McArthur, MD, MPH Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: January 19, 2023 Expired: January 18, 2024
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AstraZeneca Pharmaceuticals
Daiichi Sankyo, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings